H&T Presspart has launched the Vytal ready-to-use snap-fit closure solution for advanced therapeutics, including biologics, mAbs, and cell-based therapies. The solution addresses issues specific to complex biotherapeutics, which the company highlights as key to the pharmaceutical market. H&T Presspart, a division of Heitkamp & Thumann Group, develops and manufactures drug delivery components and devices for the pharmaceutical industry.